Form 4: GE HealthCare Executive Acquires Shares and Stock Options
SEC Form 4 Filing
Kenneth R. Stacherski, Chief Supply Chain & Service Officer of GE HealthCare Technologies Inc., reports acquisition of shares and stock options.
Summary
- On March 3, 2025, Kenneth R. Stacherski, Chief Supply Chain & Service Officer of GE HealthCare Technologies Inc., acquired 5,060 shares of common stock and 14,472 employee stock options.
- The shares were awarded as restricted stock units, and the stock options have a strike price of $86.45.
- 33% of the restricted stock units will vest on September 3, 2026, 33% on September 3, 2027, and 34% on September 3, 2028.
- Similarly, 33% of the employee stock options will become exercisable on September 3, 2026, 33% on September 3, 2027, and 34% on September 3, 2028, subject to certain conditions.
- Following these transactions, Stacherski directly owns 31,671 shares of GE HealthCare common stock and 14,472 derivative securities.
Sentiment
Score: 6
Explanation: Neutral sentiment as it's a standard insider transaction report. The acquisition of shares and options could be seen as a positive signal, but it's not overwhelmingly so.
Positives
- The acquisition of shares and stock options by a key executive could be interpreted as a sign of confidence in the company's future performance.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. These filings are closely watched by investors seeking insights into management's perspective on the company's value and future prospects.
Comparison to Industry Standards
- Executive compensation packages, including stock options and restricted stock units, are common across publicly traded companies, particularly in the healthcare technology sector.
- The vesting schedules for these equity grants are fairly standard, typically spanning three to four years to incentivize long-term performance.
- Companies like Siemens Healthineers and Philips also utilize similar equity-based compensation strategies for their executives.
Stakeholder Impact
- The transactions reported on this form may influence investor sentiment regarding GE HealthCare's stock.
Key Dates
| Date | Description |
|---|---|
| 03/03/2025 | Date of transaction: Acquisition of common stock and employee stock options. |
| 03/05/2025 | Date of signature on the Form 4 filing. |
| 09/03/2026 | First vesting date for 33% of restricted stock units and exercisable date for 33% of employee stock options. |
| 09/03/2027 | Second vesting date for 33% of restricted stock units and exercisable date for 33% of employee stock options. |
| 09/03/2028 | Final vesting date for 34% of restricted stock units and exercisable date for 34% of employee stock options. |
| 03/03/2035 | Expiration date of the employee stock options. |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.